Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Operating Leases (2023 - 2025)

Profound Medical has reported Operating Leases over the past 3 years, most recently at $72000.0 for Q2 2025.

  • Quarterly results put Operating Leases at $72000.0 for Q2 2025, changed N/A from a year ago — trailing twelve months through Jun 2025 was $72000.0 (changed N/A YoY), and the annual figure for FY2024 was $203000.0, down 59.72%.
  • Operating Leases for Q2 2025 was $72000.0 at Profound Medical, down from $136000.0 in the prior quarter.
  • Over the last five years, Operating Leases for PROF hit a ceiling of $504000.0 in Q4 2023 and a floor of $72000.0 in Q2 2025.
  • Median Operating Leases over the past 3 years was $169500.0 (2024), compared with a mean of $228750.0.
  • Peak annual rise in Operating Leases hit 59.72% in 2024, while the deepest fall reached 59.72% in 2024.
  • Profound Medical's Operating Leases stood at $504000.0 in 2023, then plummeted by 59.72% to $203000.0 in 2024, then tumbled by 64.53% to $72000.0 in 2025.
  • The last three reported values for Operating Leases were $72000.0 (Q2 2025), $136000.0 (Q1 2025), and $203000.0 (Q4 2024) per Business Quant data.